BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3
92889 results:

  • 1. Evaluation of an E6/E7 PCR-capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer.
    Yin J; Li Y; Song C; Liu Y; Zhao J; Zhao D; Zhang S; Zhang X; Zhao F; Qiao Y
    J Med Virol; 2024 Jun; 96(6):e29716. PubMed ID: 38818787
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
    Yang H; Chen Y; Huang X; Gu Y; Chen Z; Mao W
    Int J Med Sci; 2024; 21(7):1213-1226. PubMed ID: 38818465
    [No Abstract]    [Full Text] [Related]  

  • 3. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
    Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
    BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
    Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
    Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
    Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
    Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule.
    Gedamu D; Shimels T; Kassie D; Chanyalew Z; Eyasu M
    JCO Glob Oncol; 2024 May; 10():e2300322. PubMed ID: 38815179
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Surgical and multimodal treatment of metastatic oesophageal cancer: retrospective cohort study.
    Knipper K; Lemties J; Krey T; Lyu SI; Wirsik NM; Schiffmann LM; Fuchs HF; Gebauer F; Schröder W; Popp FC; Quaas A; Schlößer HA; Bruns CJ; Schmidt T
    BJS Open; 2024 May; 8(3):. PubMed ID: 38814750
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis.
    Parvathareddy SK; Siraj AK; Siraj N; Ahmed SO; Al-Rasheed M; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Front Endocrinol (Lausanne); 2024; 15():1326976. PubMed ID: 38812819
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Current Diagnostic Performance of MRI-Based Radiomics for Glioma Grading: A Meta-Analysis.
    De Maria L; Ponzio F; Cho HH; Skogen K; Tsougos I; Gasparini M; Zeppieri M; Ius T; Ugga L; Panciani PP; Fontanella MM; Brinjikji W; Agosti E
    J Integr Neurosci; 2024 May; 23(5):100. PubMed ID: 38812383
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Study on mechanism of inhibiting proliferation of head and neck cancer cells by citral, active ingredient of lemon essential oil].
    Chen L; Zhang YJ; Qin HW; Hu WJ; Liu YJ; Xiao GS; DU HH; Yang DL
    Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2364-2375. PubMed ID: 38812137
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
    Fang Q; Yuan J; Zhang X; Dai L; Luo R
    BMC Cancer; 2024 May; 24(1):656. PubMed ID: 38811899
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
    Yang X; Zheng X; Hu S; Huang J; Zhang M; Huang P; Wang J
    BMC Cancer; 2024 May; 24(1):654. PubMed ID: 38811891
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
    Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
    BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessment of the Dosimetric Index from IMRT and Rapid arc Plan for Oropharyngeal cancer with Simultaneous Integrated Boost (SIB) Technique in Combination with EUD-based NTCP and TCP Radiobiological Models.
    Dashnamoorthy S; Jeyasingh E; Rajamanickam K; Ahmed I
    Asian Pac J Cancer Prev; 2024 May; 25(5):1515-1528. PubMed ID: 38809623
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic Ability of Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Shete MV; Shete AV; Buva K; Channe PP; Sapkal R; Nerkar Rajbhoj A
    Asian Pac J Cancer Prev; 2024 May; 25(5):1477-1486. PubMed ID: 38809619
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Deep Learning-Based Prediction of Radiation Therapy Dose Distributions in Nasopharyngeal Carcinomas: A Preliminary Study Incorporating Multiple Features Including Images, Structures, and Dosimetry.
    Wang Y; Piao Z; Gu H; Chen M; Zhang D; Zhu J
    Technol Cancer Res Treat; 2024; 23():15330338241256594. PubMed ID: 38808514
    [No Abstract]    [Full Text] [Related]  

  • 19. The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.
    Shi C; Ju H; Zhou R; Xu S; Wu Y; Gu Z; Wang Y; Chen W; Huang X; Han Y; Sun S; Li C; Wang M; Zhou G; Zhang Z; Li J; Ren G
    BMC Med; 2024 May; 22(1):215. PubMed ID: 38807144
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma.
    Chen P; Fu C; Shen L; Fei Z; Luo M; Chen Y; Li H
    BMC Health Serv Res; 2024 May; 24(1):676. PubMed ID: 38807104
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4645.